See also this year's filing and all EDGAR filings for this company.
PDF Report 0001404644_2021_Neoleukin_Therapeutics_Inc.pdf
Logs
| warning | Ignoring company because Expenses is zero | pre-agg | {'balance_sheet': {'company_id': '0001404644', 'EntityCommonStockSharesOutstanding': 42326033, 'Assets': 210519000, 'AssetsCurrent': 194522000, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 347000, 'Liabilities': 19303000, 'LiabilitiesAndStockholdersEquity': 210519000, 'LiabilitiesCurrent': 7889000, 'LiabilitiesNoncurrent': 11306000, 'NetIncome': -33277000, 'PropertyPlantAndEquipmentNet': 3570000, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 12080000, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 108000, 'remainder_LiabilitiesAndStockholdersEquity': 191216000, 'remainder_NetIncome': -33277000, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001404644')"} |
Edgar->Model Mapping
